N-Ethylheptedrone is a recreational designer drug from the substituted cathinone family, with stimulant effects. It is a homologue of related drugs such as ethcathinone, N-ethylbuphedrone and N-ethylhexedrone but with a longer pentyl side chain. It was first identified in Hungary in 2019,[1][2] and has since been reported in New Zealand.[3]

N-Ethylheptedrone
Identifiers
  • 2-(ethylamino)-1-phenylheptan-1-one
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H23NO
Molar mass233.355 g·mol−1
3D model (JSmol)
  • O=C(C(CCCCC)NCC)c1ccccc1

See also

edit

References

edit
  1. ^ European Monitoring Center for Drugs and Drug Addiction (December 2020). New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. An update from the EU Early Warning System (PDF). Luxembourg: Publications Office of the European Union. doi:10.2810/921262. ISBN 9789294975584.
  2. ^ Lajtai A, Mayer M, Lakatos Á, Kuzma M, Miseta A (November 2020). "New psychoactive versus conventional stimulants - a ten-year review of casework in Hungary". Legal Medicine. 47. Tokyo, Japan: 101780. doi:10.1016/j.legalmed.2020.101780. PMID 32882537. S2CID 221496728.
  3. ^ "New cathinone N-Ethylheptedrone detected". Drug Information and Alerts. Aotearoa New Zealand. 29 June 2020.